Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
they are both vital to your daily well-being and cellular function
How does the telehealth consultation work
In May 2026, At the EASL Congress 2026, MetaVia presented promising late-breaking Phase 1 clinical trial results for DA-1726, an investigational dual GLP-1 and glucagon receptor agonist under development for obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Metabolic Boost: Helps your body burn fat more efficiently
(2024) reported that neither semaglutide nor the dual GIP/GLP-1 agonist tirzepatide influenced disease-related pathology, behavior, or cognitive function in 5XFAD and APP/PS1 mouse models of Alzheimers disease when administered after the establishment of pathology (Forny Germano et al., 2024)
US$ 26.01
US$ 22.87
US$ 29.03
US$ 21.33
US$ 27.46
US$ 21.24
